BioWorld MedTech

July 27, 2011

Combination of molecular tests best at detecting thyroid cancer

ATLANTA — A picture displaying what appears to be part of a female's abdomen pops up on the screen – with the words next to it "The fastest growing cancer among women isn't what you think." (Medical Device Daily) Read More

Studies support Cellvizio use in GI, urology, and more

Report from Europe: First five patients treated in TriVascular's OVATION trial

Washington roundup: FDA's 'when-to-file' guidance limits predicates to those cited

Financings roundup: HCA to offer $1 billion of its secured and unsecured notes

MDD's food for med-tech thought

Deals roundup: OraSure buys DNA Genotek for close to $53M in cash

Agreements/contracts: CareFusion to distribute ResMed Stellar ventilators

HIT roundup: New mobile app to help decipher medical tests

Med-Tech Notes

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....